Get started

MMJ

MMJ confirms change in directionASX Medicinal Cannabis Stock Confirms change of direction. As we can see that the price has closed above the LinReg while the LinReg is still trending down. This confirms a major change in direction for the price. We also can see that the Price is above the 20 MA and the MA has just turned into an upward direction. Also The MACD and StochRSI are now both having upward momentum. Overall this is great for long term investors, I am expecting sideways/slightly down movement in the short term, but as direction in MACD and StochRSI is recent we should continue up for abit more. This is All My Opinion based on how I read the charts.
MLong
by GlobalTrader_
GLDFF Golden Leaf HLDGS LTD, Massive Gains! MMJ Rush?keeping it simple. It seems to have bounced higher then the previous low and has been squeezing long on the WEEKLY. This is bullish in the MMJ market at the moment, and has been over looked due to the mainstream stocks. They have a positive revenue report. I dont see any sell signals currently, just a small pull back to retest the higher levels, with possible breakout. This is a long hold for me, as Ive played the regular MMJ stocks already and some are just too far up as it is. Momentum is also bullish. Happy trading, debating and speculating! FOLLOW FOR UPDATES, and check out my other crazy accurate charts, including the only Tilray chart before it blew up 400%.
GLong
by ToddGreen
MMJ breakout imminent MMJ saw capitulation on 28 Aug marking a reversal to the upside and now a bull flag pattern has formed indicating a possible breakout pending volume confirmation as marked on the chart. With approval of PhytoTech sale to HVT expected later this month plus LABS to list on the TSXV also this month; such announcements should attract some attention (and the required volume). The sector as a whole (globally) appears to be gaining some momentum given the recreational use of marijuana in Canada is officially to be legalised on Oct. 17 (Canadian Legalization).
MLong
by HerbHash
3
Tilray INC, TLRY. IPO release, high risk trading!lets keep it simple. if you havnt check out my other crazy accurate charts, then go ahead! I dont like charts without data, but this recent IPO release should be positive for the chart. We can only really look at smaller time frames for this since its out for a few days, im playing bounce zones. No long terming here. we have buy signals starting to stack on the 15, and reaching a level of resistance. Lets see how it plays out. Not much else here to look at, mostly speculation. I want everyone to win! Happy trading, debating and speculating!
NASDAQ:TLRY
by ToddGreen
SING, Singlepoint INC. High Risk Trading, Massive potential.Lets keep this one kinda simple. I've been watching SING for quite some time now, and before I started charting, had seen the last rise from 250 to 600, which has lead me to start charting this as well for future reference. Some things to note, this year SING has been fairly active, with a soon to be Crypto wallet release and MMJ -3.12% involvement along with recent news of their delivery system. If you zoom out, we can see a semi weird chart, and a huge "wedge". I've drawn a wedge inside the bigger wedge for a potential breakout to the top area of the wedge , or failed breakout to the bottom of the wedge where I've labeled a safer green buy zone. We have some buy signals on the 4 hr 0.56% , but nothing to be buying on. You can also see the Ichimoku crossing bullish for a moment, and now directing to a bearish cross once again, but not yet. This is a short trade, as I wouldn't hold this for longer then it takes to reach its wedge walls, with possible 50% to 350% gains from the buy zone to top of wedge . This is not a trade I would recommend since you could loose just as much as you gain, I play with this one for fun, fun coupons!
OTC:SING
by ToddGreen
MPX Buy OpportunityEntry @ .63 - 50% pull back from last run Stop Loss @ .57 Target1 @ 1.10 - Fib. Extension 1.272 Target2 @ 1.30 - Fib. Extension 1.618 Last 2 runs have gone from the low to 1.618 Fib Extension, let's see if this pattern continues for at least one more cycle. In the long run the company has a lot of upside potential in the MJ Market. MPX is Multi-State and Multi National with businesses in Arizona and Massachusetts, and an agreement to acquire operations in Nevada, a letter of intent to acquire dispensary and production licenses in Maryland and an application for a license in Canada, with plans to operate a 74,343 square foot cultivation and production facility in Owen Sound, Ontario. Add a joint venture with Panaxia to develop proprietary, smokeless pharma-grade products using cannabis, and the company finds itself in a position to capitalize not only on the recreational side of things but on the pharmaceutical side as well. As an Arizona native I can personal speak to their brand recognition here in the concentrate market. Consistent, high quality products in nicer packaging than the local competitors keeps customers returning for more time and time again (at least this customer lol). The company recently put out a video where Scott Boyles (Chief Executive Officer) briefly discussed their partnership with Rotogro (ASX: RGI) and the potential for this growing technology to bring their price per gram produced below $1.00. It will be worth watching to see how this relationship develops over time. Happy Trading!
MLong
by F4RM_Az
FDA Approval "coming soon"From a post on ihub- an investor emailed investor relations and received this response $$$ to: info@viadermalicensing.com cc: sales@viadermalicensing.com subject: Update mailed-by: gmail.com Hello, I have a few questions: 1-Can we expect a PR with a FDA approval this week or next for your product for treating Premature Ejaculation? 2-Are sales rolling out this quarter for Viabecline? 3-Will the lawsuit be dropped or settled this quarter? Will ViaDerma prevail? 4-Hasn't the efficacy already been done for Viabecline? Why have you started a new independent study in Texas to prove Viabecline's efficacy in treating diabetic foot wounds? 5-How much revenue do you expect from the grass roots THC and non-THC Cannabinoids, both in a patch form, roll on and spray signed with the Canadian company? Are your plans to sell licensing agreements to major producers? Thank you ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ info@viadermalicensing.com 3:08 PM (17 hours ago) FDA approval is on track. No delays are expected. Stand by for updates on that Rollout is also still on time and should be out by the of the quarter (one month from now) We received a continuance to submit our reply to the lawsuit. That's usually pretty standard. We will report developments as they happen but we feel very strongly we will prevail. We cant say too much until after we file our official reply with the court Efficacy has been done but the reason for the independent study is to show we do it better. Can't answer any revenue guidance question yet until we release that to the public. Hopefully soon. Stay tuned for more news in the near future. We expect to report on some of these and other developments shortly. Thanks Investor Relations (310) 734 6111
OTC:VDRMLong
by Cryptocol
VDRM Brings in Ivan Klarich" ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has hired Mr. Ivan Klarich, who is an expert in managing the launching of "Go to Market" strategies for new product compliance. The Company wants to avoid the pitfalls often found in the launching a new product or product line. The Company wants to assure a solid strategy behind the launch for the labeling, marketing and distribution. The "Quality Control" plan will assure the product meets strict guidelines, starting with the manufacturer all the way through to the point of purchase. The Company plans to continue to hire several experts in the specialty pharmaceutical field as the Company rolls out an aggressive growth plan for 2017 and the years ahead." Very excited for this PR and what it means for the long run for VDRM. Anyone who has been following my posts knows I'm very long long on this company in 2017. I think we may see a 20% green day today, but even if we continue to go back down a bit I have no worries and will continuing buying more. VDRM long and strong! Millionaires will be made
OTC:VDRMLong
by Cryptocol